Having shown last week that its opioid alternative can reduce post-surgery pain, Tris Pharma is back with another slice of clinical data to show that the drug is less likely to be abused.

Tris Pharma has reported positive topline outcomes from its ALLEVIATE-1 Phase III trial of cebranopadol for treating moderate-to-severe acute pain in individuals post-abdominoplasty surgery.

This valuable study reports on the critical role of ANKRD5 (ANKEF1) in sperm motility and male fertility. However, the supporting data remain incomplete. This work will be of interest to biomedical ...

The season premiere sees Tristyn and Kamohai purchase an abandoned 1950’s home sight unseen and without an inspection. When ...

Bestselling author Veronica Roth, the creator of the Divergent franchise, reflects on the book series' most divisive ...

Bowie sings the “My Death” lyrics exactly as they were written for the 1968 off-Broadway musical Jacques Brel Is Alive and ...

Allergic reactions to vitamin B12 are rare, but real. The reason may sound strange, but it's true - an allergy to cobalt.

The Cavs point guard bounced back from a broken jaw to post career numbers for the first half of this season. Here's how.

Barbe girls basketball coach Trey Digiglia lit a fire under his team at halftime Friday with the District 3-5A championship ...

Tris Pharma has set its sights on an FDA filing for pipeline drug cebranopadol before the end of this year after the drug achieved significant pain relief in abdominoplasty patients in a late ...

Torsional stress in chromatin plays a fundamental role in cellular functions, influencing key processes such as transcription, replication, and chromatin organization. Transcription and other ...

VIJAYAWADA: BJP MP D Purandeswari raised critical questions in the Lok Sabha on Thursday, pertaining to the progress of ...